IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against Geron Corporation
LOS ANGELES, CA / ACCESSWIRE / March 29, 2018 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Geron Corporation ("Geron" or "the Company") (GERN) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Investors who purchased the Company's shares are encouraged to contact the firm.
If you are a shareholder who suffered a loss, click here to participate.
We also encourage you to contact Brian Schall, or Sherin Mahdavian, of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.
The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. On March 27, 2017, STAT published a report by Adam Feuerstein stating that Geron's recent stock gains were due to "flimsy" claims regarding the efficacy of imetelstat, Geron's experimental treatment for myelofibrosis. The report states that available data for imetelstat undercuts Geron's representations as to the drug's efficacy. When the truth was revealed to the investing public, shares of Geron fell $0.83 or over 13% to close at $5.15 per share on March 27, 2018. Geron shares continue to fall sharply during intraday trading on March 28, 2018, causing shareholders harm.
The Schall Law Firm represents investors around the world, and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
CONTACT:
The Schall Law Firm
Brian Schall, Esq.,
Sherin Mahdavian, Esq.,
Schallfirm.com
SOURCE: The Schall Law Firm
